Study: CBD-Infused Biomimetic Nanoparticles Show Neuroprotective Effects in Stroke Model
- The study in Molecular Pharmaceutics Journal presents a novel CBD-based nanoparticle therapy targeting multiple biological processes involved in ischemic stroke.
- Researchers developed a multifunctional nanoformulation combining CBD with polysaccharides and apigenin to address the ischemic cascade, the complex damage process after stroke.
- Nanoparticles coated with macrophage membranes evade immune clearance, accumulate at brain injury sites, reduce oxidative stress, and support mitochondrial stability.
- In rat models, the treatment reduced brain damage, neuroinflammation, and neuronal death by suppressing inflammatory pathways (NLRP3, NF-κB), showing enhanced neuroprotection versus single-target therapies.
A new study published in Molecular Pharmaceutics Journal examines a novel approach to treating ischemic stroke using a cannabidiol (CBD)-based nanoparticle designed to target multiple aspects of the condition’s underlying biology.
Researchers from Yantai Institute of Technology, Yantai Center for Food and Drug Control, and Guangxi University developed a multifunctional nanoformulation that combines CBD with other plant-derived compounds, including polysaccharides and apigenin. The formulation is designed to address the complex “ischemic cascade,” a series of damaging processes that occur in the brain following a stroke.
The nanoparticles were coated with macrophage membranes, allowing them to evade immune clearance and more effectively reach damaged brain tissue. According to the study, this design helped the particles accumulate at the site of injury while reducing harmful oxidative stress and supporting mitochondrial stability.
In a rat model of ischemic stroke, the treatment led to reduced brain damage, lower levels of neuroinflammation, and decreased neuronal cell death. Researchers also observed improved overall neuroprotective effects compared to conventional approaches that focus on a single target.
The study found that these benefits were linked to the suppression of key inflammatory signaling pathways, specifically NLRP3 and NF-κB, which are known to play a role in stroke-related damage.
Researchers say the findings highlight the potential of combining CBD with advanced drug delivery systems to improve treatment outcomes for stroke. While the results are preclinical and require further validation, the study provides a foundation for exploring cannabinoid-based therapies in neurological conditions where multiple biological pathways are involved.